Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-12

Clinical Trial Update: Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update on adipose-derived stem cells for complex perianal fistulas in Crohn's disease; trial status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adipose-Derived Stem Cells (adipose-derived stem cells)

Snippet

Sponsor: Tigenix S.A.U. | Conditions: Complex Perianal Fistula, Crohn Disease | Phase 3 | Status: TERMINATED